Back to Search
Start Over
Relationship Between Statin-associated Muscle Symptoms, Serum Vitamin D and Low-density Lipoprotein Cholesterol - A Cross-sectional Study.
- Source :
-
European endocrinology [Eur Endocrinol] 2020 Oct; Vol. 16 (2), pp. 137-142. Date of Electronic Publication: 2020 Oct 06. - Publication Year :
- 2020
-
Abstract
- Introduction: Statin-associated muscle symptoms (SAMS) can lead to medication non-adherence among statin users. There is a complex relationship between SAMS, vitamin D and low-density lipoprotein cholesterol (LDL-C). The objective of this study was to evaluate the relationship between vitamin D, LDL-C and occurrence of SAMS.<br />Methods: This was a cross-sectional study in patients using statins. Thorough patient histories were taken, a clinical examination was conducted and SAMS were recorded. Levels of vitamin D, creatine phosphokinase (CPK) and LDL-C were measured. These parameters were compared amongst statin users with SAMS and those without SAMS. Levels of vitamin D and LDL-C were converted into percentiles and their relationship with SAMS was evaluated in terms of odds ratio. Receiver operating characteristics (ROC) were drawn, taking vitamin D and LDL-C as predictors of SAMS.<br />Results: A total of 121 statin users were enrolled in this study. Thirty-eight patients (31.4%) presented with SAMS. Significantly lower levels of serum vitamin D were observed amongst statin users with SAMS compared with those without SAMS (19.8 ± 9.67 ng/mL versus 25.0 ± 14.6 ng/mL; 95% confidence interval -10.4 to -0.07; p=0.04). With vitamin D levels less than or equal to 5th, 10th and 25th percentile, the chances of occurrence of SAMS were significantly higher, but not at the 50th percentile (corresponding vitamin D level of 20.21 ng/mL). LDL-C did not show any conclusive relationship with SAMS. ROC curves showed a significant discrimination for vitamin D levels, but not for LDL-C.<br />Conclusion: Statin users with low levels of vitamin D are at increased risk of developing SAMS. However, LDL-C status of statin users failed to predict any meaningful association with SAMS. Given the small sample size of this study, these results should be regarded as preliminary.<br />Competing Interests: Disclosures: Harsheen Kaur, Jagjit Singh, Jeet Ram Kashyap, Ravi Rohilla, Harmanjit Singh, Shivani Jaswal and Rajiv Kumar have no financial or non-financial relationships or activities to declare in relation to this article.<br /> (© Touch Medical Media 2020.)
Details
- Language :
- English
- ISSN :
- 1758-3780
- Volume :
- 16
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- European endocrinology
- Publication Type :
- Academic Journal
- Accession number :
- 33117445
- Full Text :
- https://doi.org/10.17925/EE.2020.16.2.137